GALLICCHIO, Margherita
 Distribuzione geografica
Continente #
NA - Nord America 4.278
EU - Europa 2.441
AS - Asia 1.475
AF - Africa 33
OC - Oceania 31
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 14
Totale 8.293
Nazione #
US - Stati Uniti d'America 4.213
CN - Cina 713
IT - Italia 506
DE - Germania 323
IE - Irlanda 288
SG - Singapore 238
SE - Svezia 234
UA - Ucraina 211
FR - Francia 199
DK - Danimarca 149
FI - Finlandia 146
KR - Corea 132
GB - Regno Unito 110
VN - Vietnam 78
PL - Polonia 73
AT - Austria 69
IN - India 66
CA - Canada 46
JP - Giappone 46
ID - Indonesia 41
TR - Turchia 33
AU - Australia 30
IR - Iran 30
BE - Belgio 29
HK - Hong Kong 26
TW - Taiwan 21
MX - Messico 19
CH - Svizzera 17
NL - Olanda 15
RU - Federazione Russa 15
EU - Europa 13
CZ - Repubblica Ceca 12
PT - Portogallo 11
TH - Thailandia 10
SN - Senegal 9
UZ - Uzbekistan 9
BR - Brasile 8
PH - Filippine 8
DZ - Algeria 7
ES - Italia 6
GH - Ghana 6
MY - Malesia 5
NO - Norvegia 5
SA - Arabia Saudita 5
EG - Egitto 4
IL - Israele 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
CL - Cile 3
HR - Croazia 3
JO - Giordania 3
PE - Perù 3
SI - Slovenia 3
SR - Suriname 3
AR - Argentina 2
GR - Grecia 2
IQ - Iraq 2
TN - Tunisia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
EC - Ecuador 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
Totale 8.293
Città #
Chandler 659
Ann Arbor 621
Beijing 318
Dublin 287
Houston 243
Singapore 171
Ashburn 162
Jacksonville 159
Dearborn 156
Torino 137
Fairfield 136
Nyköping 131
Villeurbanne 121
Wilmington 110
Hangzhou 104
Princeton 104
Medford 100
Columbus 79
Frankfurt am Main 76
Warsaw 67
Woodbridge 66
Dong Ket 65
Vienna 65
Turin 63
Fremont 56
Cambridge 51
Pisa 44
Seattle 42
Boardman 40
Jakarta 38
Redwood City 30
Shanghai 30
Brussels 28
Boston 24
Buffalo 24
Milan 24
Nanjing 23
Munich 22
New York 21
Washington 21
Shenyang 20
Guangzhou 19
Falls Church 16
Norwalk 16
Los Angeles 15
Taipei 15
Tokyo 15
Toronto 15
Verona 15
Rome 13
San Diego 13
Santa Clara 13
Ankara 12
Brisbane 12
Hefei 12
Montréal 12
Hong Kong 11
London 11
Helsinki 10
Mumbai 10
Southend 10
Zhengzhou 10
Kunming 9
Baltimore 8
Des Moines 8
Hebei 8
Melbourne 8
Mexico 8
Nürnberg 8
Tübingen 8
Wuhan 8
Brno 7
Chennai 7
Edinburgh 7
Liverpool 7
Mountain View 7
Padova 7
Accra 6
Central 6
Chengdu 6
Guiyang 6
Lachine 6
Phoenix 6
Portiragnes 6
Redmond 6
Seoul 6
Shiraz 6
São Paulo 6
Atakum 5
Belfast 5
Bethesda 5
Changsha 5
Chongqing 5
Düsseldorf 5
Gandhinagar 5
Istanbul 5
Jinan 5
Marseille 5
Messina 5
Nanchang 5
Totale 5.254
Nome #
Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer 568
SYNTHESIS, CHARACTERIZATION AND CELL VIABILITY TEST OF SIX VANADYL COMPLEXES WITH ACETYLACETONATE DERIVATIVES 462
Antiproliferative Effects of new Vanadyl Complexes with Acetilacetonate Derivatives on non-Tumor and Tumor Cell Lines 405
In the search for new NLRP3 inhibitors: chemical modulation of the 1-(piperidin-4-yl)-1,3-dihydro-2 Hbenzo[d]imidazole-2-one scaffold 286
BRAF V600E is a determinant of sensitivity to proteasome inhibitors. 277
EPR and photophysical characterization of six bioactive oxidovanadium(IV) complexes in the conditions of in vitro cell tests 240
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer 197
Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643 168
Antiproliferative, antioxidant and antimicrobial activities of extracts obtained from Sinapis alba L. and Sinapis nigra L. 158
Analyzing Cysteine Site Neighbors in Proteins to Reveal Dimethyl Fumarate Targets 143
Knock-in of oncogenic mutations in human somatic cells as a tool to identify genoselective compounds 128
[Prevention and treatment of febrile neutropenia] 125
Antiproliferative, Proapoptotic, Antioxidant and Antimicrobial Effects of Sinapis nigra L. and Sinapis alba L. Extracts 121
Strategies to overcome resistance to anti-EGFR monoclonal antibodies in colorectal cancer 118
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3 114
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. 112
Unveiling of BRAF V600E Mutant Cells Sensitivity to Proteasome Inhibitors Using an Isogenic Cell Based Screening 111
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES 110
EMERGENCE OF KRAS MUTATIONS AND ACQUIRED RESISTANCE TO ANTI EGFR THERAPY IN COLORECTAL CANCER 110
Adhesion of polymorphonuclear cells to endothelial cells is physiologically inhibited by Gas6 108
Commiphora myrrha (Nees) Engl. extracts: Evaluation of antioxidant and antiproliferative activity and their ability to reduce microbial growth on fresh-cut salad 106
Synthesis, characterization and cell uptake of nanoparticles for a novel approach to radionuclide therapy: a feasibility study 106
Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide 104
Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: an in vitro study 102
Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor 99
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 97
Modeling tumor progression and identifying genotype-drug interactions by the sequential introduction of cancer mutations into the genome of human normal cells 94
Knock in of cancer mutations in human cells predicts pharmacologicalresponse to targeted therapies 90
Antiapoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional mycardial I/R 89
Antiproliferative effect of cannabinoids and CBD-derived compounds in human cell lines 87
Mutation of BAX occurs infrequently in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. 86
The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma. 85
Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29) 83
Molecular characterization of HHV-8 positive primary effusion lymphoma reveals pathogenetic and histogenetic features of the disease. 82
Pharmacological characterization of new NLRP3 inflammasome inhibitors. 82
Effetto antiadesivo dell’interazione GAS6-endotelio 81
GAS6 inhibits granulocyte adhesion to endothelial cells. 79
Substance P induces COX-2 expression in Human Umbilical Vein Endothelial Cells 77
Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus 75
GAS6 inhibits granulocyte adhesion to endothelial cells 75
Design of specific tools to evaluate the Cost Of Illness (COI) of Rheumatoid Arthritis 74
Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression 73
Effetti del celecoxib sull’espressione di ICAM-1 e VCAM-1 nelle HT29 73
Nanoparticles Based on Fructose and Alkaly-Earth Halogenides with Second Harmonic Generation properties for applications as bio-sensors and for Radiotherapy. 72
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells 71
GAS6, the ligand of Axl and Rse receptors, is expressed in hematopoietic tissue but lacks mitogenic activity. 71
Generation of endogenous hydrogen sulphide by cystathionine gamma-lyase limits renal ischaemia/reperfusion injury and dysfunction 71
Celecoxib decreases ICAM-1 and VCAM-1 expression in HT29 cell line 70
Role of GAS6 on adhesion of human polymorphonuclear cells to vascular endothelium in normoxia and hypoxia 69
Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction 69
Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor 68
Isogenic mutant human cells: a new tool for personalized cancer medicine 68
The adhesion of human neutrophils to endothelial cells: the role of GAS6. 67
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells 64
Celecoxib modulates the expression of adhesion molecules in colon cancer cells 63
Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells 63
Expression of COX-2, iNOS and MAPKs in colorectal adenomas 62
Targeting NLRP3 inflammasome: development of new covalent and non-covalent inhibitors of ATPase activity 62
The adhesion of neutrophils to endothelial cells: the role of GAS6 62
Substance P-induced cycloxygenase-2 expression in polymorphonuclear cells 61
Gas 6 inhibits granulocytes adhesion to endothelial cells 61
The adhesion of neutrophils to endothelial cells evoked by Substance P: effects of COX-2 inhibitors 61
Substance P-induced cyclooxygenase-2 expression in polymorphonuclear cells 60
Hematopoietic growth factors in autologous transplantation (Review) 60
EVALUATION OF THE ANTIPYROPTOTIC ACTIVITY OF NEW INFLAMMASOME INHIBITORS 60
ANTIPROLIFERATIVE EFFECT OF CANNABINOIDS IN HUMAN CELL LINES 59
NEW NON-COVALENT INHIBITORS OF NLRP3 INFLAMMASOME ATPASE ACTIVITY 58
New inhibitors of NLRP3 inflammasome activation: pharmacological characterization in differentiated THP-1. 57
Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes. 56
Evaluation of in vitro anti-inflammatory activity of some 2-alkyl-4,6-dimethoxy-1,3,5-triazines 53
Effects of vanadyl complexes with acetylacetonate derivatives on non-tumor and tumor cell lines 52
Isogenic K-Ras mutant cancer cells: A novel platform for drug profiling 51
The adhesion of neutrophils to endothelial cells evoked by Substance P: effects of COX-2 inhibitors. 50
Indomethacin Inhibits Proliferation In Cells Harbouring PIK3CA Mutations 48
Glycogen synthase kinase-3b inhibition reduces transient cerebral ischemia/reperfusion injury in the rat hippocampus 47
Regulation of Ca2+ movements by cyclovirobuxine D in ECV304 endothelial cells 46
Primitive hematopoietic stem cells show a polyclonal pattern in myelodysplastic syndromes 46
Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation 44
The adhesion of human neutrophils to endothelial cells: the role of GAS6 44
Glycogen synthase kinase-3 inhibition reduces transient cerebral ischemia/reperfusion injury in the rat hippocampus 43
Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat 38
Evaluation of in-vitro anti-inflammatory activity of some 2-alkyl-4,6-dimethoxy-1,3,5-triazines 37
Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion 36
Vanadium Compounds Inhibit Cell Proliferation Via Mapk And Cell Cycle Arrest 35
Glycogen synthase kinase-3beta inhibition reduces transient cerebral ischemia/reperfusion injury in the rat hippocampus 31
EFFECT OF THERANOSTIC PHOSPHOLIPIDIC SRCL2/SRI2AND β-D FRUCTOPYRANOSE BASED NANOPARTICLES ON CELL VIABILITY AND UPTAKE 29
Evidence-Based Anti-Diabetic Properties of Plant from the Occitan Valleys of the Piedmont Alps 29
Effect of cetuximab-5-fluorouracil conjugates on the proliferation of colorectal cancer cells. 28
Effects of new hydroxyazoles inhibitors of AKR1C3 on vitality of prostate and colorectal cancer cell lines 24
Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas 12
Portable Voltammetry: A Rapid and Efficient Technique for Determining UV Filters in Cosmetics: A Comparative Study with HPLC-PDA and HPLC-MS/MS 5
Totale 8.553
Categoria #
all - tutte 24.489
article - articoli 0
book - libri 0
conference - conferenze 9.755
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.007 0 0 0 0 79 259 135 71 157 113 112 81
2020/2021856 113 43 47 45 50 31 88 29 112 83 33 182
2021/20221.308 131 125 101 126 50 54 70 61 51 62 268 209
2022/20231.914 185 167 44 222 153 427 132 177 220 39 93 55
2023/2024848 93 139 62 48 43 110 25 76 8 63 70 111
2024/2025504 53 112 91 232 16 0 0 0 0 0 0 0
Totale 8.553